Response to the report, "A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury" by Sharp et al
Abrams MB, Nilsson I, Kjell J, Lewandowski S, Codeluppi S, Eriksson U, Olson L
Comment on
A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury. [Exp Neurol. 2014]